Table 1 Characteristics of study participants at enrolment, by study phase
Variable | Overall N = 3042 | Pre-RAS N = 761 | Post-RAS N = 2281 | P-value comparing pre-post RAS |
|---|---|---|---|---|
% | % | % | ||
Age | 0.80 | |||
0–2 years | 57.6 | 57.2 | 57.7 | |
2–5 years | 42.4 | 42.8 | 42.3 | |
Sex | 0.93 | |||
Male | 53.1 | 53.2 | 53.1 | |
Female | 46.9 | 46.8 | 47.0 | |
Health Zone | < 0.001 | |||
Ipamu | 37.1 | 30.1 | 39.4 | |
Kenge | 36.2 | 40.9 | 34.6 | |
Kingandu | 26.7 | 29.0 | 26.0 | |
Enrolment location | < 0.001 | |||
CHW | 5.4 | 7.9 | 4.6 | |
PHC | 94.6 | 92.1 | 95.4 | |
General iCCM danger signs | < 0.001 | |||
No | 33.6 | 46.7 | 29.2 | |
Yes | 66.4 | 53.4 | 70.8 | |
Referral completion | 0.81 | |||
No | 33.6 | 33.1 | 33.8 | |
Yes | 66.4 | 66.9 | 66.2 | |
Malaria test | 0.002 | |||
Negative/Not done | 47.8 | 52.7 | 46.2 | |
Positive | 52.2 | 47.3 | 53.8 | |
Anaemia | 0.06 | |||
No/mild anaemia/not determined | 66.5 | 69.3 | 65.6 | |
Severe anaemia (≤ 5 g/dL) | 33.5 | 30.7 | 34.4 |